Dropprint Genomics - About the company
Dropprint Genomics is an acqui-hired company based in San Francisco (United States), founded in 2019 by Jimmie Ye, Rachel E. Gate and Meena Subramaniam. It operates as a Developer of genomics data sets for drug discovery. Dropprint Genomics has raised $150K in funding from Y Combinator, with last known valuation of $*****. The company has 726 active competitors, including 72 funded and 68 that have exited. Its top competitors include companies like Strand Life Sciences, BGI and Hexagon Bio.
Company Details
Dropprint Genomics is developing single-cell technology to profile gene data sets for the development of drugs for immune-based diseases. The company uses its single-cell technology and machine learning models to identify gene data sets and characterize the data from large populations for understanding the immune system.
- Website
- dropprintgen.com
- Email ID
- *****@dropprintgen.com
Key Metrics
Founded Year
2019
Location
San Francisco, United States
Stage
Acqui-Hired
Total Funding
$150K in 1 round
Latest Funding Round
Last Known Valuation
$***** as on Mar 17, 2020
Investors
Ranked
190th among 726 active competitors
Similar Companies
Sign up to download Dropprint Genomics' company profile
Dropprint Genomics's funding and investors
Dropprint Genomics has raised a total funding of $150K over 1 round. Its latest funding round was a Seed round on Mar 17, 2020 for $*****. 1 investor participated in its latest round. Dropprint Genomics has 2 institutional investors.
Here is the list of recent funding rounds of Dropprint Genomics:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Mar 17, 2020 | 8009455 | Seed | 7286292 | 8005616 | 6015730 | 4316915 |
Access funding benchmarks and valuations. Sign up today!View details of Dropprint Genomics's funding rounds and investors
Dropprint Genomics' founders and board of directors
Founder? Claim ProfileThe founders of Dropprint Genomics are Jimmie Ye, Rachel E. Gate and Meena Subramaniam. Rachel E. Gate is the CEO of Dropprint Genomics.
Here are the details of Dropprint Genomics' key team members:
- Jimmie Ye: Co-Founder & Advisor of Dropprint Genomics.
- Rachel E. Gate: Co-Founder & CEO of Dropprint Genomics.
- Meena Subramaniam: Co-Founder & CTO of Dropprint Genomics.
View details of Dropprint Genomics's Founder profiles and Board Members
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Dropprint Genomics's Competitors and alternates
Top competitors of Dropprint Genomics include Strand Life Sciences, BGI and Hexagon Bio. Here is the list of Top 10 competitors of Dropprint Genomics, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Strand Life Sciences 2000, Bengaluru (India), Acquired | Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery | $34.9M | 74/100 | |
2nd | Provider of services in genome sequencing | - | 64/100 | ||
3rd | Hexagon Bio 2017, Menlo Park (United States), Series B | Provider of bioinformatics tools for the analysis of microbial genomic sequencing data | $206M | 62/100 | |
4th |  Cellanome 2020, Palo Alto (United States), Series B | Developer of the omic data platform for researchers | $119M | 59/100 | |
5th |  Enara Bio 2016, Oxford (United Kingdom), Series B | Developer of T-cell based cancer-cell interface for therapeutics | $84.1M | 53/100 | |
6th | Provider of genomic DNA tests for assessing predisposition to diseases & personalized nutrition | $1.81M | 52/100 | ||
7th | Berry Genomics 2010, Beijing (China), Public | Provider of genetic testing products and tests | $16M | 50/100 | |
8th | Provider of services for research application across life sciences industries | - | 49/100 | ||
9th | Synthesize Bio 2023, Seattle (United States), Series A | Provider of AI-generated gene expression data for biological research purposes | $10M | 49/100 | |
10th | AI-based oncology therapy plan solution for professionals | $43M | 49/100 | ||
190th |  Dropprint Genomics 2019, San Francisco (United States), Acqui-Hired | Developer of genomics data sets for drug discovery | $150K | 29/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Dropprint Genomics's competitors? Click here to see the top ones
Dropprint Genomics's Investments and acquisitions
Dropprint Genomics has made no investments or acquisitions yet.
Reports related to Dropprint Genomics
Here is the latest report on Dropprint Genomics's sector:
News related to Dropprint Genomics
•
Immunai acquires single-cell data developer Dropprint Genomics to build out its immune system atlasFierce Biotech•Mar 25, 2021•Immunai Technologies, Dropprint Genomics
•
Immunai Acquires Dropprint Genomics and Strengthens Leadership Team with Experts in Immunology to Expand Target Discovery CapabilitiesWebwire•Mar 25, 2021•Immunai Technologies, Dropprint Genomics
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Dropprint Genomics
Explore our recently published companies
- Nic Beddoe Insurance - Truckee based, Unfunded company
- Jerry Tench Insurance - San Francisco based, Unfunded company
- Cesar Carrillo Insurance - Island Lake based, Unfunded company
- Clinton Raines - Atlanta based, Unfunded company
- Brian Himmelman State Farm - Conifer based, Unfunded company
- Curt Sumpter State Farm - Silver Spring based, Unfunded company
